Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 112563701000001116 | Tezacaftor (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 112563801000001113 | Tezacaftor | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tezacaftor | Is a | Substance with cystic fibrosis transmembrane conductance regulator potentiator mechanism of action | false | Inferred relationship | Existential restriction modifier | ||
| Tezacaftor | Is a | Respiratory system agent | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tezacaftor 100mg / Ivacaftor 150mg tablets | Has specific active ingredient | False | Tezacaftor | Inferred relationship | Existential restriction modifier | |
| Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) | Has specific active ingredient | False | Tezacaftor | Inferred relationship | Existential restriction modifier | |
| Tezacaftor 100mg / Ivacaftor 150mg tablets 28 tablet | Has specific active ingredient | False | Tezacaftor | Inferred relationship | Existential restriction modifier | |
| Symkevi 100mg/150mg tablets (Vertex Pharmaceuticals (Europe) Ltd) 28 tablet 4 x 7 tablets | Has specific active ingredient | False | Tezacaftor | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR